EUVIMEDEUVIMED entdecken
Crossref

Clinical outcomes of palliative treatment for gastric bleeding from incurable gastric cancer

Shusuke Yagi, Satoshi Ida, Ken Namikawa, Masaru Hayami, Rie Makuuchi, Koshi Kumagai, Manabu Ohashi, Takeshi Sano, Souya Nunobe

Surgery Today · 2023-03 · 53 (3) · 360-368

DOI: 10.1007/s00595-022-02567-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery Today, online erschienen am 06.08.2022. Verfasst von Shusuke Yagi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Deciding palliative treatment for gastric bleeding from incurable gastric cancer (IGC) is worrying considering different patient situations and the lack of comprehensive assessment of palliative treatment. We evaluated the clinical outcomes and prognostic factors after palliative treatment for gastric bleeding from IGC. METHODS: We enrolled 48 consecutive patients with gastric bleeding from IGC who underwent palliative surgery (PS) or palliative radiotherapy (PRT). RESULTS: Of the 48 patients, 23 underwent PS and 25 received PRT. More patients who had an Eastern Cooperative Oncology Group-Performance Status (ECOG-PS) ≥ 2 or who received chemotherapy underwent PRT than underwent PS. Severe complications were observed in 2 (8.6%) patients after PS. After PRT, 22 patients achieved hemostasis (88%), but rebleeding was found in 10 (40%). Chemotherapy was introduced after palliative treatment for 21 (91.3%) patients in the PS group and 17 (68%) patients in the PRT group. The median survival time (MST) of patients with and without chemotherapy after PS was 12.5 and 3.1 months, respectively (p ≤ 0.001), while the MST of patients with and without chemotherapy after PRT was 6.5 and 1.6 months (p < 0.001). Multivariate analyses identified ECOG-PS, tumor size, and chemotherapy after palliative treatment as independent risk factors. CONCLUSIONS: Palliative treatment strategies for gastric bleeding should be determined with consideration of the general condition, previous chemotherapy, and chemotherapy after palliative treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsHumansPalliative CareRetrospective Studies

Stichwörter der Autor:innen

Gastric cancerPalliative radiotherapyPalliative surgeryTumor bleeding

Autor:innen und Institutionen

  • Department of Gastroenterology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Department of Surgery, National Center for Global Health and Medicine, Tokyo, Japan.
  • Department of Gastroenterology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. souya.nunobe@jfcr.or.jp.

Zitieren

APA

Yagi, S., Ida, S., Namikawa, K., Hayami, M., Makuuchi, R., Kumagai, K., Ohashi, M., Sano, T., & Nunobe, S. (2023). Clinical outcomes of palliative treatment for gastric bleeding from incurable gastric cancer. Surgery Today, 53(3), 360-368. https://doi.org/10.1007/s00595-022-02567-8

Vancouver

Yagi S, Ida S, Namikawa K, Hayami M, Makuuchi R, Kumagai K, et al. Clinical outcomes of palliative treatment for gastric bleeding from incurable gastric cancer. Surgery Today. 2023;53(3):360-368. doi:10.1007/s00595-022-02567-8

BibTeX
@article{Yagi2023,
  author = {Yagi, Shusuke and Ida, Satoshi and Namikawa, Ken and Hayami, Masaru and Makuuchi, Rie and Kumagai, Koshi and Ohashi, Manabu and Sano, Takeshi and Nunobe, Souya},
  title = {Clinical outcomes of palliative treatment for gastric bleeding from incurable gastric cancer},
  journal = {Surgery Today},
  year = {2023},
  volume = {53},
  number = {3},
  pages = {360--368},
  doi = {10.1007/s00595-022-02567-8}
}
Kostenlos starten →